Trial Profile
AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE PHASE 1, CLINICAL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF TETANUS VACCINE OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Tetanus vaccine (Primary)
- Indications Tetanus
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 23 Oct 2015 Status changed to completed.
- 19 Feb 2014 New trial record